- Programme Committee
Sponsors of Obesity Update 2021
2021 Headline Sponsor
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark.
Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease.
Novo Nordisk employs about 45,000 people in 80 countries and markets its products in around 170 countries.
For more information, visit novonordisk.co.uk
Novo Nordisk has provided sponsorship to Bioscientifica to cover the costs of Obesity Update Online 2021. Novo Nordisk has had no influence over the creation, development or content of this online meeting and full control remains the responsibility of Bioscentifica (with the exception of the symposium session indicated on the meeting agenda).
Rhythm Pharmaceuticals is dedicated to transforming the care of people living with rare genetic diseases of obesity.
To learn more, please visit:
For medical inquiries, please email firstname.lastname@example.org and note you attended Obesity Update.
View our short video on Rare Genetic Diseases of Obesity HERE
Rhythm Pharmaceuticals has provided sponsorship to Bioscientifica to cover the costs of Obesity Update Online 2021. Rhythm Pharmaceuticals has had no influence over the creation, development or content of this online meeting and full control remains the responsibility of Bioscentifica.
Do you want to sponsor the conference in 2021?
Please contact Sophie Tovey for further information: email@example.com